These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
372 related items for PubMed ID: 19210644
1. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study. Yoshihara S, Ono M, Yamada Y, Fukuda H, Abe T, Arisaka O. Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644 [Abstract] [Full Text] [Related]
2. Usefulness of suplatast tosilate, a Th2 cytokine inhibitor based on the Th1/Th2 ratio for allergic disease in children: a retrospective study. Yoshihara S, Fukuda H, Arisaka O. Arzneimittelforschung; 2011 Aug; 61(7):421-4. PubMed ID: 21899211 [Abstract] [Full Text] [Related]
3. Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate. Kimata H. Ann Allergy Asthma Immunol; 1999 Mar; 82(3):293-5. PubMed ID: 10094221 [Abstract] [Full Text] [Related]
4. [The effect of suplatast tosilate on immunological parameters for the patients with atopic dermatitis]. Suto H, Mitsuishi K, Hira K, Uchida T, Unno T, Ogawa H, Yoshiike T, Takamori K. Arerugi; 2000 Dec; 49(12):1163-72. PubMed ID: 11197882 [Abstract] [Full Text] [Related]
5. Suplatast tosilate alters DC1/DC2 balance in peripheral blood in bronchial asthma. Yokomura K, Suda T, Matsuda H, Hashizume H, Asada K, Suzuki K, Chida K. J Asthma; 2005 Sep; 42(7):567-70. PubMed ID: 16169790 [Abstract] [Full Text] [Related]
6. [The effect of suplatast tosilate on the patients with atopic dermatitis--relationship between clinical symptoms and immunological parameters]. Higashi N, Niimi Y, Aoki M, Fujimoto K, Suzuki K, Numano K, Kawana S. Arerugi; 2003 Nov; 52(11):1065-73. PubMed ID: 14685038 [Abstract] [Full Text] [Related]
7. Effect of suplatast tosilate on goblet cell metaplasia in patients with asthma. Hoshino M, Fujita Y, Saji J, Inoue T, Nakagawa T, Miyazawa T. Allergy; 2005 Nov; 60(11):1394-400. PubMed ID: 16197471 [Abstract] [Full Text] [Related]
8. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5. Murakami T, Yamanaka K, Tokime K, Kurokawa I, Tsutsui H, Nakanishi K, Mizutani H. Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748 [Abstract] [Full Text] [Related]
9. Prophylactic effectiveness of suplatast tosilate in children with asthma symptoms in the autumn: a pilot study. Yoshihara S, Yamada Y, Fukuda H, Tsuchiya T, Ono M, Fukuda N, Kanno N, Arisaka O. Allergol Int; 2014 Jun; 63(2):199-203. PubMed ID: 24561769 [Abstract] [Full Text] [Related]
10. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate. Ishiura Y, Fujimura M, Yamamoto H, Nobata K, Ishiguro T, Ogawa H, Myou S. Arzneimittelforschung; 2008 Jun; 58(6):297-302. PubMed ID: 18677972 [Abstract] [Full Text] [Related]
11. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on cough variant asthma. Shioya T, Satake M, Sano M, Kagaya M, Watanabe A, Sato K, Ito T, Ito N, Sasaki M, Miura M. Eur J Clin Pharmacol; 2002 Jun; 58(3):171-6. PubMed ID: 12107601 [Abstract] [Full Text] [Related]
12. [Cytokine production by peripheral blood mononuclear cells in bronchial asthma treated with suplatast tosilate]. Yamasawa H, Oshikawa K, Sugiyama Y. Arerugi; 2001 Jun; 50(6):513-9. PubMed ID: 11517513 [Abstract] [Full Text] [Related]
13. [Inhibitory effect of suplatast tosilate on eosinophil migration]. Kobayashi Y, Nagata M, Yamamoto H, Sakamoto Y. Arerugi; 2000 Jul; 49(7):600-3. PubMed ID: 10944827 [Abstract] [Full Text] [Related]
14. Long-term monotherapy with suplatast tosilate in patients with mild atopic asthma: a pilot comparison with low-dose inhaled fluticasone. Shiga M, Horiguchi T, Kondo R, Miyazaki J, Hirose M, Otake Y, Hata H, Tachikawa S. Asian Pac J Allergy Immunol; 2011 Jun; 29(2):134-42. PubMed ID: 21980828 [Abstract] [Full Text] [Related]
15. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Tokyo Joshi-Idai Asthma Research Group. Tamaoki J, Kondo M, Sakai N, Aoshiba K, Tagaya E, Nakata J, Isono K, Nagai A. Lancet; 2000 Jul 22; 356(9226):273-8. PubMed ID: 11071181 [Abstract] [Full Text] [Related]
16. Prevention of asthma by ketotifen in infants with atopic dermatitis. Iikura Y, Naspitz CK, Mikawa H, Talaricoficho S, Baba M, Sole D, Nishima S. Ann Allergy; 1992 Mar 22; 68(3):233-6. PubMed ID: 1546818 [Abstract] [Full Text] [Related]
17. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice. Furonaka M, Hattori N, Tanimoto T, Senoo T, Ishikawa N, Fujitaka K, Haruta Y, Yokoyama A, Kohno N. J Pharmacol Exp Ther; 2009 Jan 22; 328(1):55-61. PubMed ID: 18832650 [Abstract] [Full Text] [Related]
18. Add-on effects of suplatast tosilate in bronchial asthma patients treated with inhaled corticosteroids. Sano T, Nakamura Y, Yanagawa H, Bando H, Nii A, Yoshida S, Sone S, Higashishikoku Asthma Research Group. Lung; 2003 Jan 22; 181(4):227-35. PubMed ID: 14692563 [Abstract] [Full Text] [Related]
19. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients. Yoshida M, Aizawa H, Inoue H, Matsumoto K, Koto H, Komori M, Fukuyama S, Okamoto M, Hara N. J Asthma; 2002 Sep 22; 39(6):545-52. PubMed ID: 12375715 [Abstract] [Full Text] [Related]
20. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. Warner JO, ETAC Study Group. Early Treatment of the Atopic Child. J Allergy Clin Immunol; 2001 Dec 22; 108(6):929-37. PubMed ID: 11742270 [Abstract] [Full Text] [Related] Page: [Next] [New Search]